TY  - GEN
AU  - Hassani,Yasmine
AU  - Hochart,Caroline
AU  - Hassani,Lamia
AU  - Taillibert,Sophie
AU  - Xuan,Khe Hoang
AU  - Bellanger,Agnès
TI  - [Monitoring and evaluation tools for irinotecan and bevacizumab in glioblastoma: from prescription to patient's information]
SN  - 1769-6917
PY  - 2012///0711
KW  - Antibodies, Monoclonal, Humanized
KW  - administration & dosage
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - adverse effects
KW  - Bevacizumab
KW  - Brain Neoplasms
KW  - drug therapy
KW  - Camptothecin
KW  - Contraindications
KW  - Drug Monitoring
KW  - methods
KW  - Family
KW  - France
KW  - General Practice
KW  - Glioblastoma
KW  - Humans
KW  - Irinotecan
KW  - Medical Oncology
KW  - Off-Label Use
KW  - Pamphlets
KW  - Patient Education as Topic
KW  - Pharmaceutical Services
KW  - Pharmacovigilance
KW  - Prescription Drugs
KW  - economics
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1684/bdc.2012.1573
ER  -